OCX | OncoCyte Corporation
Category: Biotechnology company
Industry: Biotechnology company Quick infos Headquarters: California, United States Trade prices Volume: Market Cap: 385.00M Prev closed: 4.06 Open: 4.14 High: 4.55 Low: 4.06 52 week low: 1.15 52 week high: 6.57 Dividends: No Dividends Next ER: May 17, 2021 After Market Closes
Company Profile Oncocyte is a molecular diagnostics company whose mission is to provide actionable answers at critical decision points across the lung cancer care continuum, with the goal of improving patient outcomes by accelerating and optimizing diagnosis and treatment.
Earnings History Date EPS / Forecast Revenue / Forecast March 16, 2021 -0.0916 / -0.1055503K / 807.9KNovember 12, 2020 -0.1 / -0.0967555K / 366.67KBeat! August 12, 2020 - / -0.11- / 42.6KJuly 29, 2020 -0.14 / -0.1143K / 47.2KBeat! May 12, 2020 -0.13 / -0.1116K / 75Kview more
Historical Data Date Price Open High Low Vol Change ER May 18, 2021 4.33 4.14 4.55
4.06
547.64K 6.65% May 17, 2021 4.06 3.90 4.07
3.85
394.09K 4.24% May 14, 2021 3.89 3.89 4.08
3.83
297.12K 1.83% May 13, 2021 3.83 3.80 4.04
3.80
404.41K 1.46% May 12, 2021 3.77 3.99 4.11
3.73
653.85K -8.5% May 11, 2021 4.12 3.75 4.22
3.75
376.92K 3.26% May 10, 2021 3.99 4.32 4.32
3.99
547.48K -6.78% May 7, 2021 4.28 4.42 4.62
4.26
484.12K -3.6% May 6, 2021 4.44 4.30 4.44
4.12
631.48K 3.02% May 5, 2021 4.31 4.48 4.50
4.26
539.43K -3.36% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2009 Employees:33 Parent Organization : BioTime News
Will OncoCyte (OCX) Report Negative Q1 Earnings? What You Should Know finance.yahoo.com May 19, 2021 3:00 pm
OncoCyte Corp. to Host Earnings Call finance.yahoo.com May 19, 2021 2:30 pm
Oncocyte Announces Pricing of $35 Million Public Offering of Common Stock finance.yahoo.com May 19, 2021 8:25 am OncoCyte EPS beats by $0.05, beats on revenue seekingalpha.com May 18, 2021 4:01 am
Oncocyte Reports First Quarter 2021 Financial Results and Provides Corporate Update finance.yahoo.com May 17, 2021 4:01 pm
Medicare Coverage Determination for Molecular Testing Announced for Solid Organ Allograft Rejection, Citing Multiple Publications from OncoCyte Corporations Subsidiary Chronix Biomedical, Inc. finance.yahoo.com May 6, 2021 8:00 am
Oncocyte Enters the Rapidly Growing Immune Therapy Monitoring Market with the Closing of the Acquisition of Chronix Biomedical, Inc. finance.yahoo.com Apr 19, 2021 8:00 am Oncocyte’s DetermaIO shows correlation with immunotherapy response in bladder cancer seekingalpha.com Apr 11, 2021 9:48 am Oncocyte CEO discloses insider buying seekingalpha.com Mar 24, 2021 6:40 pm
Ronald Andrews Is The CEO, President & Director of OncoCyte Corporation (NASDAQ:OCX) And They Just Picked Up 11% More Shares finance.yahoo.com Mar 23, 2021 1:44 am Midday Stock Roundup ocbj.com Mar 18, 2021 2:46 am Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates nasdaq.com Mar 17, 2021 9:46 am CRWD, SCOR, OCX and REGI among after-hours movers seekingalpha.com Mar 17, 2021 9:46 am OncoCyte (OCX) Reports Q4 Loss, Misses Revenue Estimates nasdaq.com Mar 17, 2021 9:46 am OncoCyte: Q4 Earnings Snapshot finance.yahoo.com Mar 17, 2021 9:46 am
Oncocyte Announces Definitive Agreement to Acquire Chronix Biomedical, Inc. finance.yahoo.com Mar 17, 2021 8:00 am
Oncocyte Announces Peer-Reviewed Publication of Data Assessing Use of DetermaIO to Identify Patients Likely to Benefit from Immunotherapy Across Multiple Tumor Types finance.yahoo.com Mar 17, 2021 8:00 am OncoCyte EPS beats by $0.02, misses on revenue seekingalpha.com Mar 17, 2021 4:06 am FTC moves to hinder cross-border pharma mergers; CVS cut to neutral at Guggenheim and more in today’s analyst action seekingalpha.com Mar 15, 2021 11:19 pm Is OncoCyte Corp (OCX) a Smart Choice in Biotechnology Wednesday? investorsobserver.com Mar 11, 2021 9:46 am This company doesn't provide a dividend.
Key Persons Talk about OncoCyte Corporation below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?
